DOI: 10.5061/dryad.kwh70rzjp
title: Data for: Characterizing multi-criteria decision analysis, risk stratification, and hotspot analysis methods to optimise disease policymaking and evidence translation for medicines in low- and middle-income countries: A scoping review

description: The supplementary materials include the Preferred Reporting Items for
 Systematic Reviews and Meta-Analyses -S1 PRISMA checklist, which provides
 a structured set of sections for reporting the scoping review and contains
 key information from the paper, including the aims, specific methods, data
 sources, analyses, and how each item is addressed. It contains three
 appendices corresponding to each main section of the paper, as well as a
 list of supporting tables and figures. S1 Appendix includes data related
 to key attributes, such as the number of articles over time, geographical
 region and country, author affiliation, disease focus, and stage of
 medicine translation. S2 Appendix includes data on the specific analytical
 methods presented in the review—multi-decision criteria analysis (MDCA),
 risk stratification, and hotspot analysis—such as article summaries,
 variables, and visual tools. S3 Appendix includes data related to the grey
 literature, including the search strategies and outputs from international
 and regional organisations, conferences, and independent journals. S1
 PRISMA-Checklist S1 Appendix. Tables and figures related to the section
 'Paper and report attributes' S2 Appendix. Tables and figures
 related to the section 'Data analytical methods' S3
 Appendix. Tables and figures related to the section 'Grey
 literature'
description: # Data for: Characterizing multi-criteria decision analysis, risk
 stratification, and hotspot analysis methods to optimise disease
 policymaking and evidence translation for medicines in low- and
 middle-income countries: A scoping review Dataset DOI:
 [10.5061/dryad.kwh70rzjp](https://doi.org/10.5061/dryad.kwh70rzjp) ##
 Description of the data and file structure Data are summaries from
 information collected from published articles as part of a scoping review.
 ### Files and variables #### File: S1._PRISMA-Checklist_181225.pdf
 **Description:** Preferred Reporting Items for Systematic reviews and
 Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist, which
 provides a structured set of sections for reporting the scoping review and
 contains key information from the paper, including the aims, specific
 methods, data sources, analyses, and how each item is addressed. ####
 File: S1_Appendix._Paper_and_report_attributes_related_data_181225.pdf
 **Description:** Tables and figures summarising the number of articles
 over time, by geographical region, country, author affiliation, human
 disease, and stage of medicine translation.  Table 1. Summary of the
 number of articles published annually between 2010 and 2025 by data
 analytical method; Table 2. Summary of WHO regions represented in the
 article study locations across each analytical method; Table 3. Summary of
 countries represented in article study locations across each analytical
 method; Table 4: Summary of first and last author primary affiliation as
 well as LMIC(s) studied across each analytical method; Table 5: Summary of
 human diseases focused on across each analytical method, including
 single/multi-diseases, infectious/non-infectious diseases and exact
 disease or disease groups; Table 6: Summary of medicine translation stage
 across each analytical method;  Figure 1. Graphical presentation of the
 number of articles published annually between 2010 and 2025 by data
 analytical method; Figure 2 and Table:  Distribution of alignment between
 the country affiliation of the first and last authors and the study
 country across each analytical method. #### File:
 S2_Appendix._Data_analytical_methods_related_data_191225.pdf
 **Description:** Tables and figures summarising each analytical method,
 including article information (e.g., title, author, year, data sources)
 and visual tools presented. MCDA - Table 1: List of numbered MCDA
 articles, including title, aim(s) and date published; Table 2: The number
 and list of criteria used in each MCDA article; Table 3: The list of 20
 criteria featured in the EVIDEM ver.10 framework compared to its use in
 article 6 and potential relations with criteria in articles 1-5; Figures
 1-3. Visual tools presented for MCDA. Risk stratification - Table 4: List
 of numbered Risk Stratification articles, including title, summarised
 aim(s), date published, and type of risk stratification. Table 5: List of
 risk stratification articles that used or adapted a previously developed
 risk stratification alongside links to the original publication(s) of the
 risk stratification tools; Table 6: Number and list of the variables used
 in each risk stratification across all articles, including the articles
 that used more than one risk stratification; Table 7: Summary of risk
 group creations for non-basic risk stratification articles; Figures 4-8.
 Visual tools presented for risk stratification. Hotspot analysis - Table
 8: Summary of hotspot article characteristics; Figure 9: Visual tools
 presented for hotspot analysis. #### File:
 S3._Appendix._Grey_literature_related_data_181225.pdf
 **Description:** Tables and figures summarising the review process and
 data sources, and characteristics of related documents found. Figure 1.
 Inclusion/Exclusion criteria, example of keyword searches, and flowchart
 for ASTMH conference abstract searches; Table 1. Conference abstracts
 included. Characteristics of ASTMH abstracts describing potential risk
 stratification (*n*=1) and hotspot analysis (*n*=1) methods; Table 2.
 Conference abstracts identified with a summary of the analytical method
 focus and reasons for exclusion; Table 3 A)WHO and regional /national
 resources searched and reasons for exclusion; and References.